EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels

Adriana Ferre-Giraldo iD, Manel Castells, José Francisco Sánchez-Herrero iD, Olga López-Rodrigo, Maurizio de Rocco-Ponce, Lluís Bassas, Francesc Vigués iD, Lauro Sumoy iD, Sara Larriba iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251810122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Adriana Ferre-Giraldo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Human Molecular Genetics Group-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Prostate-Specific Antigen, Semen, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, the Generalitat de Catalunya, Ministerio de Trabajo y Economía Social through Programa Investigo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PSA screening has led to an over-diagnosis of prostate cancer (PCa) and unnecessary biopsies of benign conditions due to its low cancer specificity. Consequently, more accurate, preferentially non-invasive, tests are needed. We aim to evaluate the potential of semen sEV (small extracellular vesicles) tsRNAs (tRNA-derived small RNAs) as PCa indicators. Initially, following a literature review in the OncotRF database and high-throughput small RNA-sequencing studies in PCa tissue together with the sncRNA profile in semen sEVs, we selected four candidate 5′tRF tsRNAs for validation as PCa biomarkers. RT-qPCR analysis in semen sEVs from men with moderately elevated serum PSA levels successfully shows that the differential expression of the four tRFs between PCa and healthy control groups can be detected in a non-invasive manner. The combined model incorporating PSA and specific tRFs (5′-tRNA-Glu-TTC-9-1_L30 and 5′-tRNA-Val-CAC-3-1_L30) achieved high predictive accuracy in identifying samples with a Gleason score ≥ 7 and staging disease beyond IIA, supporting that the 5′tRF fingerprint in semen sEV can improve the PSA predictive value to discriminate between malignant and indolent prostate conditions. The in silico study allowed us to map target genes for the four 5′tRFs possibly involved in PCa. Our findings highlight the synergistic use of multiple biomarkers as an efficient approach to improve PCa screening and prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsProstate-Specific AntigenSemenBiomarkers, TumorExtracellular VesiclesHumansMaleMiddle AgedAgedRNA, TransferNeoplasm Grading

Stichwörter der Autor:innen

5′tRFsPSAbiomarkersnon-invasive diagnosis/prognosisprostate cancersemen extracellular vesiclestsRNAs

Substanzen

Prostate-Specific AntigenBiomarkers, TumorRNA, Transfer

Autor:innen und Institutionen

  • Human Molecular Genetics Group-Bellvitge Biomedical Research Institute (IDIBELL), 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • Urology Service, Bellvitge University Hospital-ICS (Institut Català de la Salut), 08908 Hospitalet de Llobregat, Barcelona, Spain.
  • High Content Genomics and Bioinformatics (HCGB)-Germans Trias i Pujol Research Institute (IGTP), 08916 Badalona, Spain.
  • Laboratory of Andrology and Sperm Bank, Andrology Service-Puigvert Foundation, 08025 Barcelona, Spain.

ORCID-Profile: Adriana Ferre-Giraldo, José Francisco Sánchez-Herrero, Francesc Vigués, Lauro Sumoy, Sara Larriba

Förderung

  • Instituto de Salud Carlos III
  • the Generalitat de Catalunya
  • Ministerio de Trabajo y Economía Social through Programa Investigo
  • Generalitat de Catalunya
  • Researchers Consolidation Program (SNS/Generalitat de Catalunya)
  • ISCIII through the Acción Estratégica en Salud 2022

Zitieren

APA

Ferre-Giraldo, A., Castells, M., Sánchez-Herrero, J. F., López-Rodrigo, O., de Rocco-Ponce, M., Bassas, L., Vigués, F., Sumoy, L., & Larriba, S. (2024). Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251810122

Vancouver

Ferre-Giraldo A, Castells M, Sánchez-Herrero JF, López-Rodrigo O, de Rocco-Ponce M, Bassas L, et al. Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251810122

BibTeX
@article{FerreGiraldo2024,
  author = {Ferre-Giraldo, Adriana and Castells, Manel and Sánchez-Herrero, José Francisco and López-Rodrigo, Olga and de Rocco-Ponce, Maurizio and Bassas, Lluís and Vigués, Francesc and Sumoy, Lauro and Larriba, Sara},
  title = {Semen sEV tRF-Based Models Increase Non-Invasive Prediction Accuracy of Clinically Significant Prostate Cancer among Patients with Moderately Altered PSA Levels},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251810122}
}
Kostenlos starten →